Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-18

Clinical Trial Update: Benzocaine Gel Toothache Dose-Response Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on benzocaine gel for toothache with dose–response results; study completed and results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzocaine Gel (benzocaine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Toothache | Phase 4 | Status: COMPLETED | Results posted: 2012-01-18